시장보고서
상품코드
2040774

압박 요법 시장 규모, 점유율 및 동향 분석 보고서 : 기술별, 최종 용도별, 유통 채널별 및 지역별 예측(2026-2033년)

Compression Therapy Market Size, Share & Trends Analysis Report By Technology (Static Compression Therapy, Dynamic Compression Therapy), By End Use (Hospitals, Specialty Clinics), By Distribution Channel, And Region Forecasts, 2026 - 2033

발행일: | 리서치사: 구분자 Grand View Research | 페이지 정보: 영문 300 Pages | 배송안내 : 2-10일 (영업일 기준)

    
    
    




가격
Unprintable PDF & Excel (Single User License) help
보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.
US $ 5,950 금액 안내 화살표 ₩ 9,269,000
Printable PDF & Excel (5-User License) help
보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.
US $ 6,950 금액 안내 화살표 ₩ 10,827,000
Printable PDF & Excel (Enterprise License) help
PDF & Excel 보고서를 동일 기업(자회사 포함)의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다. 인쇄물의 이용 범위는 파일의 이용 범위와 동일합니다.
US $ 8,950 금액 안내 화살표 ₩ 13,943,000
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

압박 요법 시장 요약

세계의 압박 요법 시장 규모는 2025년에 44억 3,000만 달러로 추정되고, 2033년까지 58억 8,000만 달러에 이를 것으로 예측되며, 2026-2033년 CAGR 3.54%를 보일 전망입니다.

이는 심부정맥혈전증(DVT), 정맥류, 림프부종, 만성정맥부전 등 정맥 및 림프계 질환의 유병률 증가에 기인합니다. 혈액순환을 개선하고 부종을 줄이기 위해 압력을 조절하여 압박을 가하는 압박 요법은 이러한 질환의 예방과 치료 모두에서 필수적인 해결책이 되고 있습니다.

또한 비만, 당뇨병, 심혈관 질환 등 만성질환의 부담이 증가하고 있으며, 순환기 질환에 취약한 세계 인구의 고령화가 빠르게 진행되고 있는 점도 시장 성장을 견인하고 있습니다. 또한, 수술 및 스포츠 부상 증가로 인해 수술 후 관리 및 재활 치료에서 압박 요법에 대한 수요가 증가하고 있습니다.

심부정맥혈전증(DVT)의 유병률 증가로 인해 합병증을 줄이기 위한 효과적인 예방 및 관리 전략이 필요해짐에 따라 압박요법 시장이 크게 확대되고 있습니다. 주로 다리의 심부정맥에 혈전이 생기는 DVT는 좌식 생활습관, 비만율 증가, 고령화, 수술 건수 증가 등의 요인으로 인해 점점 더 흔해지고 있습니다. 스타킹이나 공압 장치를 포함한 압박 요법은 혈액 순환 개선, 혈전 형성 예방, 혈전 후 합병증 위험 감소를 위해 널리 권장되고 있습니다.

  • 미국 질병예방통제센터(CDC)의 2025년 자료에 따르면, 미국에서는 매년 최대 90만 명이 정맥혈전색전증(VTE)을 앓고 있으며, 이는 이 질환이 의료 시스템에 큰 부담을 주고 있다는 것을 보여줍니다.

만성정맥부전, 정맥궤양과 같은 질환은 전 세계적으로 많은 사람들에게 영향을 미치고 있으며, 고령화, 운동부족, 비만 등의 요인이 큰 역할을 하고 있습니다. 정맥 궤양에 대한 압박 요법은 매우 효과적이기 때문에 정맥 궤양의 유병률 증가는 가까운 미래에 시장 성장을 주도할 것으로 보입니다. 또한, 정맥류에 대한 압박요법은 다른 치료법에 비해 매우 효과적입니다. 예를 들어, 미국혈관외과학회 자료에 따르면 4,000만 명의 미국인이 정맥류를 앓고 있다고 합니다. 또한, NCBI가 발표한 기사에 따르면, 매년 약 15만 건의 만성정맥부전 환자가 새로 진단되고 있으며, 이 환자들을 치료하는 데 약 5억 달러가 소요되고 있습니다.

압박요법은 환부에 적절한 압력을 가함으로써 증상 완화, 혈류 개선, 부종 감소, 치유 촉진, 합병증 예방에 도움이 됩니다. 따라서 만성 정맥 질환 관리에 있어 압박 요법의 효과에 대한 인식이 높아짐에 따라 시장 성장을 견인할 것으로 예측됩니다.

정형외과 수술 건수가 증가함에 따라 수술 후 관리 및 재활 프로토콜의 일환으로 압박 요법에 대한 수요가 증가하고 있습니다. 관절 치환술(무릎, 고관절 치환술 등), 골절 수술, 인대 재건술, 관절경 수술 등 정형외과 수술은 고령화, 스포츠 부상, 수술 기술의 발전 등의 요인으로 인해 점점 더 보편화되고 있습니다. 예를 들어, 미국 류마티스 학회 자료에 따르면, 고령화를 배경으로 미국에서 연간 시행되는 무릎 및 고관절 치환술 건수는 증가 추세에 있으며, 매년 약 79만 건의 무릎관절 치환술과 54만 4,000건의 고관절 치환술이 시행되고 있습니다. 2024년 호주 정형외과 학회 전국 관절 치환술 등록기구(AOANJRR)가 발표한 자료에 따르면, 호주에서 210만 건 이상의 정형외과 수술이 이루어졌습니다고 합니다.

정형외과 수술 후 환자는 일반적으로 수술한 사지의 부종, 염증, 운동 범위의 감소를 경험하게 됩니다. 압박 요법은 혈액 순환을 개선하고 부종을 감소시키며 수술 부위를 지지함으로써 수술 후 증상을 관리하고 회복을 촉진하는 데 매우 중요한 역할을 합니다.

비만 사례가 증가함에 따라 건강 문제를 관리하기 위한 중요한 수단으로 압박 요법의 채택이 증가하고 있습니다. 과도한 체지방 축적을 특징으로 하는 비만은 심혈관 질환(CVD), 당뇨병, 고혈압과 같은 만성 질환의 위험을 증가시킬 뿐만 아니라, 정맥 부전 및 관련 질환의 원인이 되기도 합니다. 예를 들어, International Journal of Medical Science and Clinical Invention에 게재된 논문에 따르면, 비만은 정맥 부전 및 관련 합병증의 위험을 6배 이상 높인다고 합니다. 세계비만연맹(World Obesity Federation)에 따르면, 2024년에는 전 세계적으로 10억 명 이상이 비만을 앓고 있으며, 이는 인구의 약 8명 중 1명이 비만인 셈입니다. 여기에는 약 8억 8,000만 명의 성인과 5세부터 19세까지의 어린이 및 청소년 1억 5,900만 명이 포함됩니다. 세계비만연맹이 '세계 비만의 날'(3월 4일)을 맞아 발표한 '2025 아틀라스'에 따르면, 2010년부터 2030년까지 비만인 성인 인구는 115% 이상 증가해 5억 2,400만 명에서 11억 3,000만 명에 달할 것으로 예측됩니다.

자주 묻는 질문

  • 압박 요법 시장 규모는 어떻게 예측되나요?
  • 압박 요법이 필요한 주요 질환은 무엇인가요?
  • 정맥류 환자의 수는 얼마나 되나요?
  • 압박 요법의 효과는 무엇인가요?
  • 비만이 압박 요법 시장에 미치는 영향은 무엇인가요?
  • 정형외과 수술 후 압박 요법의 필요성은 무엇인가요?

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 압박 요법 시장 : 변수, 동향, 범위

제4장 압박 요법 시장 : 기술별 추정·동향 분석

제5장 압박 요법 시장 : 최종 용도별 추정·동향 분석

제6장 압박 요법 시장 : 유통 채널별 추정·동향 분석

제7장 압박 요법 시장 : 지역별 추정·동향 분석

제8장 경쟁 구도

제1장 조사 방법과 범위

제2장 주요 요약

제3장 압박 요법 시장 : 변수, 동향, 범위

제4장 압박 요법 시장 : 기술별 추정·동향 분석

제5장 압박 요법 시장 : 최종 용도별 추정·동향 분석

제6장 압박 요법 시장 : 유통 채널별 추정·동향 분석

제7장 압박 요법 시장 : 지역별 추정·동향 분석

제8장 경쟁 구도

LSH 26.06.04

Compression Therapy Market Summary

The global compression therapy market size was estimated at USD 4.43 billion in 2025 and is projected to reach USD 5.88 billion by 2033, growing at a CAGR of 3.54% from 2026 to 2033, driven by the rising prevalence of venous and lymphatic disorders such as Deep Vein Thrombosis (DVT), varicose veins, lymphedema, and chronic venous insufficiency. Compression therapy, which applies controlled pressure to improve blood circulation and reduce swelling, has become an essential solution for both prevention and treatment of these conditions.

Growth is further fueled by the increasing burden of chronic diseases such as obesity, diabetes, and cardiovascular conditions, along with a rapidly aging global population that is more susceptible to circulatory disorders. In addition, the rising number of surgical procedures and sports-related injuries is boosting demand for compression therapy in post-operative care and rehabilitation.

The rising prevalence of Deep Vein Thrombosis (DVT) is significantly growing the compression therapy market, as the condition requires effective prevention and management strategies to reduce complications. DVT, which involves the formation of blood clots in deep veins primarily in the legs, is becoming more common due to factors such as sedentary lifestyles, increasing obesity rates, an aging population, and a higher number of surgical procedures. Compression therapy, including stockings and pneumatic devices, is widely recommended to improve blood circulation, prevent clot formation, and reduce the risk of post-thrombotic complications.

  • According to the Centers for Disease Control and Prevention (CDC) data from 2025, up to 900,000 people in the U.S. are affected by venous thromboembolism (VTE) each year, highlighting the significant burden of this condition on the healthcare system.

Conditions such as chronic venous insufficiency and venous ulcers impact many people worldwide, with factors such as aging populations, inactive lifestyles, and obesity playing a major role. Compression therapy for venous ulcers is highly effective; therefore, the rising prevalence of venous ulcers will drive market growth in the near future. Moreover, compression therapy for varicose veins is a highly effective treatment compared to other options. For instance, data from the Society for Vascular Surgery indicate that as many as 40 million Americans have varicose veins. Moreover, according to an article published by NCBI, around 150,000 new cases of chronic venous insufficiency are diagnosed each year, with approximately USD 500 million spent on the care of these patients.

Compression therapy works by applying controlled pressure to the affected limbs, helping ease symptoms, enhance blood flow, reduce swelling, and aid healing, while preventing complications. Thus, the growing awareness of compression therapy's effectiveness in managing chronic venous conditions is expected to drive market growth.

The growing number of orthopedic procedures is driving an increased need for compression therapy as part of postoperative care and rehabilitation protocols. Orthopedic surgeries, including joint replacements (such as knee or hip replacements), fracture repairs, ligament reconstructions, and arthroscopic surgeries, are becoming more common due to factors such as an aging population, sports-related injuries, and advancements in surgical techniques. For instance, according to data from the American College of Rheumatology, the number of knee and hip replacements performed annually in the U.S. is on the rise due to the aging population, with approximately 790,000 knee replacements and 544,000 hip replacements performed each year. According to data published by the Australian Orthopedic Association National Joint Replacement Registry (AOANJRR) in 2024, more than 2.1 million orthopedic procedures were performed in Australia.

After an orthopedic procedure, patients commonly experience swelling, inflammation, and reduced mobility in the operated limbs. Compression therapy plays a vital role in managing these postoperative symptoms and in providing recovery by improving blood circulation, reducing swelling, and supporting the surgical site.

The increasing cases of obesity have led to an increase in the adoption of compression therapy as a crucial device in managing health-related concerns. Obesity, characterized by excessive body fat accumulation, not only increases the risk of chronic disorders such as CVD, diabetes, & hypertension but also contributes to venous insufficiency and associated disorders. For instance, an article published in the International Journal of Medical Science and Clinical Invention suggests that obesity increases the risk of venous insufficiency and associated complications by more than sixfold. As per the World Obesity Federation, in 2024, more than one billion people worldwide were living with obesity, which is about one in eight people. This includes nearly 880 million adults, and 159 million children and adolescents aged 5-19. The World Obesity Federation's 2025 Atlas, published on World Obesity Day (4 March), projects that the total number of adults living with obesity will increase by more than 115% between 2010 and 2030, from 524 million to 1.13 billion.

Global Compression Therapy Market Report Segmentation

This report forecasts revenue growth at regional and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the compression therapy market report based on technology, end use, distribution channel, and region.

  • Technology Outlook (Revenue, USD Million, 2021 - 2033)
  • Static Compression Therapy
    • Compression Bandages
    • Compression Stockings
    • Compression Tape
    • Others Compression Garments
  • Dynamic Compression Therapy
    • Compression Pumps
    • Compression Sleeves
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals
  • Specialty Clinics
  • Home Healthcare
  • Physician's Office
  • Nursing Homes
  • Others
  • Distribution Channel Outlook (Revenue, USD Million, 2021 - 2033)
  • Institutional Sales
  • Retail Sales
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • Thailand
    • South Korea
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Segment Definitions
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Compression Therapy Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Ancillary Market Outlook
    • 3.1.2. Parent Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Increasing prevalence of chronic vein disorders
      • 3.2.1.2. Growing number of orthopedic procedures
      • 3.2.1.3. Growing Incidence of obesity
      • 3.2.1.4. Growing aging population
      • 3.2.1.5. Rising awareness about non-invasive treatment options
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Alternative treatment method
      • 3.2.2.2. Lack of awareness in rural and underdeveloped regions
    • 3.2.3. Market Opportunities Analysis
      • 3.2.3.1. Increasing adoption of home-based treatment solutions
      • 3.2.3.2. Technological advancements
      • 3.2.3.3. Growing demand in emerging markets
      • 3.2.3.4. Expansion of e-commerce and retail distribution channels
      • 3.2.3.5. Untapped rural healthcare markets
    • 3.2.4. Market Challenge Analysis
      • 3.2.4.1. Patient discomfort and compliance issues
      • 3.2.4.2. Limited reimbursement policies in developing regions
  • 3.3. Compression Therapy Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political & Legal Landscape
      • 3.3.2.2. Economic and Social Landscape
      • 3.3.2.3. Technological landscape

Chapter 4. Compression Therapy Market: Technology Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Compression Therapy Market Movement Analysis
  • 4.3. Global Compression Therapy Market Size & Trend Analysis, by Technology, 2021 to 2033 (USD Million)
  • 4.4. Static Compression Therapy
    • 4.4.1. Static Compression Therapy Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.4.1.1. Compression Bandages
        • 4.4.1.1.1. Compression Bandages Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.4.1.2. Compression Stockings
        • 4.4.1.2.1. Compression Stockings Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.4.1.3. Compression Tape
        • 4.4.1.3.1. Compression Tape Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.4.1.4. Other Compression Garments
        • 4.4.1.4.1. Other Compression Garments Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5. Dynamic Compression Therapy
    • 4.5.1. Dynamic Compression Therapy Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.5.1.1. Compression Pumps
        • 4.5.1.1.1. Compression Pumps Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.5.1.2. Compression Sleeves
        • 4.5.1.2.1. Compression Sleeves Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Compression Therapy Market: End Use Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Compression Therapy Market Movement Analysis
  • 5.3. Global Compression Therapy Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
  • 5.4. Hospitals
    • 5.4.1. Hospitals Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5. Specialty Clinics
    • 5.5.1. Specialty Clinics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.6. Home Healthcare
    • 5.6.1. Home Healthcare Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.7. Physician's Office
    • 5.7.1. Physician's Office Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.8. Nursing Homes
    • 5.8.1. Nursing Homes Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.9. Others
    • 5.9.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Compression Therapy Market: Distribution Channel Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global Compression Therapy Market Movement Analysis
  • 6.3. Global Compression Therapy Market Size & Trend Analysis, by Distribution Channel, 2021 to 2033 (USD Million)
  • 6.4. Institutional Sales
    • 6.4.1. Institutional Sales Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5. Retail Sales
    • 6.5.1. Retail Sales Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Compression Therapy Market: Regional Estimates & Trend Analysis By Technology, By End Use, By Distribution Channel

  • 7.1. Regional Dashboard
  • 7.2. Market Size & Forecasts and Trend Analysis, 2021 to 2033
  • 7.3. North America
    • 7.3.1. North America Compression Therapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.3.2. U.S.
      • 7.3.2.1. Key Country Dynamics
      • 7.3.2.2. Competitive Scenario
      • 7.3.2.3. Regulatory Scenario
      • 7.3.2.4. Reimbursement Scenario
      • 7.3.2.5. U.S. Compression Therapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.3.3. Canada
      • 7.3.3.1. Key Country Dynamics
      • 7.3.3.2. Competitive Scenario
      • 7.3.3.3. Regulatory Scenario
      • 7.3.3.4. Reimbursement Scenario
      • 7.3.3.5. Canada Compression Therapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.3.4. Mexico
      • 7.3.4.1. Key Country Dynamics
      • 7.3.4.2. Competitive Scenario
      • 7.3.4.3. Regulatory Scenario
      • 7.3.4.4. Reimbursement Scenario
      • 7.3.4.5. Mexico Compression Therapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.4. Europe
    • 7.4.1. Europe Compression Therapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.2. UK
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Competitive Scenario
      • 7.4.2.3. Regulatory Scenario
      • 7.4.2.4. Reimbursement Scenario
      • 7.4.2.5. UK Compression Therapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.3. Germany
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Competitive Scenario
      • 7.4.3.3. Regulatory Scenario
      • 7.4.3.4. Reimbursement Scenario
      • 7.4.3.5. Germany Compression Therapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.4. France
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Competitive Scenario
      • 7.4.4.3. Regulatory Scenario
      • 7.4.4.4. Reimbursement Scenario
      • 7.4.4.5. France Compression Therapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.5. Italy
      • 7.4.5.1. Key Country Dynamics
      • 7.4.5.2. Competitive Scenario
      • 7.4.5.3. Regulatory Scenario
      • 7.4.5.4. Reimbursement Scenario
      • 7.4.5.5. Italy Compression Therapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.6. Spain
      • 7.4.6.1. Key Country Dynamics
      • 7.4.6.2. Competitive Scenario
      • 7.4.6.3. Regulatory Scenario
      • 7.4.6.4. Reimbursement Scenario
      • 7.4.6.5. Spain Compression Therapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.7. Denmark
      • 7.4.7.1. Key Country Dynamics
      • 7.4.7.2. Competitive Scenario
      • 7.4.7.3. Regulatory Scenario
      • 7.4.7.4. Reimbursement Scenario
      • 7.4.7.5. Denmark Compression Therapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.8. Sweden
      • 7.4.8.1. Key Country Dynamics
      • 7.4.8.2. Competitive Scenario
      • 7.4.8.3. Regulatory Scenario
      • 7.4.8.4. Reimbursement Scenario
      • 7.4.8.5. Sweden Compression Therapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.9. Norway
      • 7.4.9.1. Key Country Dynamics
      • 7.4.9.2. Competitive Scenario
      • 7.4.9.3. Regulatory Scenario
      • 7.4.9.4. Reimbursement Scenario
      • 7.4.9.5. Norway Compression Therapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Asia Pacific Compression Therapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.2. Japan
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Competitive Scenario
      • 7.5.2.3. Regulatory Scenario
      • 7.5.2.4. Reimbursement Scenario
      • 7.5.2.5. Japan Compression Therapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.3. China
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Competitive Scenario
      • 7.5.3.3. Regulatory Scenario
      • 7.5.3.4. Reimbursement Scenario
      • 7.5.3.5. China Compression Therapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.4. India
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Competitive Scenario
      • 7.5.4.3. Regulatory Scenario
      • 7.5.4.4. Reimbursement Scenario
      • 7.5.4.5. India Compression Therapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.5. South Korea
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Competitive Scenario
      • 7.5.5.3. Regulatory Scenario
      • 7.5.5.4. Reimbursement Scenario
      • 7.5.5.5. South Korea Compression Therapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.6. Australia
      • 7.5.6.1. Key Country Dynamics
      • 7.5.6.2. Competitive Scenario
      • 7.5.6.3. Regulatory Scenario
      • 7.5.6.4. Reimbursement Scenario
      • 7.5.6.5. Australia Compression Therapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.7. Thailand
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Competitive Scenario
      • 7.5.7.3. Regulatory Scenario
      • 7.5.7.4. Reimbursement Scenario
      • 7.5.7.5. Thailand Compression Therapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6. Latin America
    • 7.6.1. Latin America Compression Therapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.2. Brazil
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Competitive Scenario
      • 7.6.2.3. Regulatory Scenario
      • 7.6.2.4. Reimbursement Scenario
      • 7.6.2.5. Brazil Compression Therapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.3. Argentina
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Competitive Scenario
      • 7.6.3.3. Regulatory Scenario
      • 7.6.3.4. Reimbursement Scenario
      • 7.6.3.5. Argentina Compression Therapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.7. Middle East & Africa
    • 7.7.1. Middle East & Africa Compression Therapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.2. South Africa
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Competitive Scenario
      • 7.7.2.3. Regulatory Scenario
      • 7.7.2.4. Reimbursement Scenario
      • 7.7.2.5. South Africa Compression Therapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.3. Saudi Arabia
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Competitive Scenario
      • 7.7.3.3. Regulatory Scenario
      • 7.7.3.4. Reimbursement Scenario
      • 7.7.3.5. Saudi Arabia Compression Therapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.4. UAE
      • 7.7.4.1. Key Country Dynamics
      • 7.7.4.2. Competitive Scenario
      • 7.7.4.3. Regulatory Scenario
      • 7.7.4.4. Reimbursement Scenario
      • 7.7.4.5. UAE Compression Therapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.5. Kuwait
      • 7.7.5.1. Key Country Dynamics
      • 7.7.5.2. Competitive Scenario
      • 7.7.5.3. Regulatory Scenario
      • 7.7.5.4. Reimbursement Scenario
      • 7.7.5.5. Kuwait Compression Therapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Market Participant Categorization
  • 8.2. Key Company Profiles
    • 8.2.1. Essity Aktiebolag (publ).
      • 8.2.1.1. Company Overview
      • 8.2.1.2. Financial Performance
      • 8.2.1.3. Service Benchmarking
      • 8.2.1.4. Strategic Initiatives
    • 8.2.2. Cardinal Health
      • 8.2.2.1. Company Overview
      • 8.2.2.2. Financial Performance
      • 8.2.2.3. Service Benchmarking
      • 8.2.2.4. Strategic Initiatives
    • 8.2.3. Julius Zorn GmbH
      • 8.2.3.1. Company Overview
      • 8.2.3.2. Financial Performance
      • 8.2.3.3. Product Benchmarking
      • 8.2.3.4. Strategic Initiatives
    • 8.2.4. Hartmann AG
      • 8.2.4.1. Company Overview
      • 8.2.4.2. Financial Performance
      • 8.2.4.3. Product Benchmarking
      • 8.2.4.4. Strategic Initiatives
    • 8.2.5. Medi GmbH & Co.
      • 8.2.5.1. Company Overview
      • 8.2.5.2. Financial Performance
      • 8.2.5.3. Product Benchmarking
      • 8.2.5.4. Strategic Initiatives
    • 8.2.6. SIGVARIS
      • 8.2.6.1. Company Overview
      • 8.2.6.2. Financial Performance
      • 8.2.6.3. Product Benchmarking
      • 8.2.6.4. Strategic Initiatives
    • 8.2.7. ArjoHuntleigh
      • 8.2.7.1. Company Overview
      • 8.2.7.2. Financial Performance
      • 8.2.7.3. Product Benchmarking
      • 8.2.7.4. Strategic Initiatives
    • 8.2.8. 3M
      • 8.2.8.1. Company Overview
      • 8.2.8.2. Financial Performance
      • 8.2.8.3. Product Benchmarking
      • 8.2.8.4. Strategic Initiatives
    • 8.2.9. Spectrum Healthcare
      • 8.2.9.1. Company Overview
      • 8.2.9.2. Financial Performance
      • 8.2.9.3. Product Benchmarking
      • 8.2.9.4. Strategic Initiatives
    • 8.2.10. Bio Compression Systems, Inc.
      • 8.2.10.1. Company Overview
      • 8.2.10.2. Financial Performance
      • 8.2.10.3. Product Benchmarking
      • 8.2.10.4. Strategic Initiatives
    • 8.2.11. Stryker
      • 8.2.11.1. Company Overview
      • 8.2.11.2. Financial Performance
      • 8.2.11.3. Product Benchmarking
      • 8.2.11.4. Strategic Initiatives
    • 8.2.12. Gottfried Medical
      • 8.2.12.1. Company Overview
      • 8.2.12.2. Financial Performance
      • 8.2.12.3. Product Benchmarking
      • 8.2.12.4. Strategic Initiatives
    • 8.2.13. Tactile Medical
      • 8.2.13.1. Company Overview
      • 8.2.13.2. Financial Performance
      • 8.2.13.3. Product Benchmarking
      • 8.2.13.4. Strategic Initiatives
  • 8.3. Heat Map Analysis/ Company Market Position Analysis
  • 8.4. Estimated Company Market Share Analysis, 2025
  • 8.5. List of Other Key Market Players
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제
문의
원하시는 정보를
찾아 드릴까요?
문의주시면 필요한 정보를
신속하게 찾아드릴게요.
02-2025-2992
kr-info@giikorea.co.kr
문의하기